Literature DB >> 12917534

Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures.

Mohammed Ahmed1, Abdulaziz Al-Sugair, Abdullah Alarifi, Abdulraof Almahfouz, Saif Al-Sobhi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12917534     DOI： 10.1097/01.RLU.0000067512.53644.FB

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  4 in total

Review 1.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

Review 2.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

3.  Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan.

Authors:  Cristina Rodríguez Rey; Aída Ortega Candil; Eliseo Vañó Galván; María Nieves Cabrera Martín; José Luis Carreras Delgado
Journal:  Nucl Med Mol Imaging       Date:  2015-06-03

4.  Childhood adrenocortical tumours: a review.

Authors:  Rosana Marques-Pereira; Luiz Delacerda; Hadriano M Lacerda; Edson Michalkiewicz; Fabiano Sandrini; Romolo Sandrini
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.